Logo image of IBTA

IBOTTA INC-CL A (IBTA) Stock Fundamental Analysis

NYSE:IBTA - New York Stock Exchange, Inc. - US4510511060 - Common Stock

73.41  +1.1 (+1.52%)

After market: 73.41 0 (0%)

Fundamental Rating

5

IBTA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 92 industry peers in the Media industry. IBTA has an excellent financial health rating, but there are some minor concerns on its profitability. IBTA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

IBTA had positive earnings in the past year.
IBTA Yearly Net Income VS EBIT VS OCF VS FCFIBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 20M -20M 40M -40M -60M

1.2 Ratios

The Return On Assets of IBTA (1.87%) is better than 64.37% of its industry peers.
With a decent Return On Equity value of 2.97%, IBTA is doing good in the industry, outperforming 60.92% of the companies in the same industry.
IBTA's Return On Invested Capital of 9.22% is amongst the best of the industry. IBTA outperforms 83.91% of its industry peers.
Industry RankSector Rank
ROA 1.87%
ROE 2.97%
ROIC 9.22%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBTA Yearly ROA, ROE, ROICIBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 50 -50 100 150

1.3 Margins

With a decent Profit Margin value of 3.04%, IBTA is doing good in the industry, outperforming 63.22% of the companies in the same industry.
IBTA has a Operating Margin of 11.18%. This is in the better half of the industry: IBTA outperforms 68.97% of its industry peers.
IBTA has a better Gross Margin (87.17%) than 96.55% of its industry peers.
Industry RankSector Rank
OM 11.18%
PM (TTM) 3.04%
GM 87.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBTA Yearly Profit, Operating, Gross MarginsIBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 20 -20 40 60 80

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IBTA is still creating some value.
The number of shares outstanding for IBTA remains at a similar level compared to 1 year ago.
IBTA has a better debt/assets ratio than last year.
IBTA Yearly Shares OutstandingIBTA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M
IBTA Yearly Total Debt VS Total AssetsIBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 7.10 indicates that IBTA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.10, IBTA belongs to the top of the industry, outperforming 91.95% of the companies in the same industry.
IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.1
ROIC/WACC1
WACC9.2%
IBTA Yearly LT Debt VS Equity VS FCFIBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

IBTA has a Current Ratio of 2.72. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IBTA (2.72) is better than 86.21% of its industry peers.
IBTA has a Quick Ratio of 2.72. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.
IBTA's Quick ratio of 2.72 is amongst the best of the industry. IBTA outperforms 87.36% of its industry peers.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.72
IBTA Yearly Current Assets VS Current LiabilitesIBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

IBTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 169.48%, which is quite impressive.
The Revenue has grown by 51.89% in the past year. This is a very strong growth!
EPS 1Y (TTM)169.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)51.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

IBTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.56% yearly.
The Revenue is expected to grow by 18.27% on average over the next years. This is quite good.
EPS Next Y-80.9%
EPS Next 2Y46%
EPS Next 3Y42.56%
EPS Next 5YN/A
Revenue Next Year18.72%
Revenue Next 2Y17.53%
Revenue Next 3Y18.27%
Revenue Next 5YN/A

3.3 Evolution

IBTA Yearly Revenue VS EstimatesIBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
IBTA Yearly EPS VS EstimatesIBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 667.36, which means the current valuation is very expensive for IBTA.
IBTA's Price/Earnings ratio is in line with the industry average.
IBTA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.29.
The Price/Forward Earnings ratio is 27.32, which means the current valuation is very expensive for IBTA.
IBTA's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 24.44. IBTA is around the same levels.
Industry RankSector Rank
PE 667.36
Fwd PE 27.32
IBTA Price Earnings VS Forward Price EarningsIBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600

4.2 Price Multiples

72.41% of the companies in the same industry are cheaper than IBTA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.13
IBTA Per share dataIBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as IBTA's earnings are expected to grow with 42.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46%
EPS Next 3Y42.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IBTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IBOTTA INC-CL A

NYSE:IBTA (1/21/2025, 8:06:42 PM)

After market: 73.41 0 (0%)

73.41

+1.1 (+1.52%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners50.41%
Inst Owner Change0.23%
Ins Owners29.09%
Ins Owner Change-1.49%
Market Cap2.25B
Analysts82.67
Price Target86.81 (18.25%)
Short Float %13.66%
Short Ratio4.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.14%
Min EPS beat(2)-52.55%
Max EPS beat(2)42.28%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.67%
Min Revenue beat(2)0.55%
Max Revenue beat(2)2.8%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.3%
EPS NY rev (1m)0%
EPS NY rev (3m)12.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.84%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE 667.36
Fwd PE 27.32
P/S 6.1
P/FCF N/A
P/OCF N/A
P/B 5.95
P/tB 5.95
EV/EBITDA 39.13
EPS(TTM)0.11
EY0.15%
EPS(NY)2.69
Fwd EY3.66%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.03
BVpS12.34
TBVpS12.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.87%
ROE 2.97%
ROCE 10.65%
ROIC 9.22%
ROICexc 78.34%
ROICexgc 78.34%
OM 11.18%
PM (TTM) 3.04%
GM 87.17%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.72
Quick Ratio 2.72
Altman-Z 7.1
F-ScoreN/A
WACC9.2%
ROIC/WACC1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)169.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-80.9%
EPS Next 2Y46%
EPS Next 3Y42.56%
EPS Next 5YN/A
Revenue 1Y (TTM)51.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year18.72%
Revenue Next 2Y17.53%
Revenue Next 3Y18.27%
Revenue Next 5YN/A
EBIT growth 1Y238.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.92%
EBIT Next 3Y54.77%
EBIT Next 5YN/A
FCF growth 1Y122.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.21%
OCF growth 3YN/A
OCF growth 5YN/A